Get started
Author

Kok Fei Chan

Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection
2018 · Kok Fei Chan, Louise A Carolan, et al. · The Journal of Infectious Diseases · 125
PDF
γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
2022 · Kok Fei Chan, Jessica Da Gama Duarte, et al. · Frontiers in Immunology · 82
PDF
Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages
2017 · Karen L Laurie, William Horman, et al. · The Journal of Infectious Diseases · 67
Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide
2018 · Kok Fei Chan, Benjamin S. Gully, et al. · Nature Communications · 54
PDF
Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection
2017 · Kok Fei Chan, Louise A. Carolan, et al. · Journal of Virology · 38
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity
2024 · Tirta M. Djajawi, Lizzy Pijpers, et al. · Cell Reports · 30
Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model
2018 · Daniil A. Korenkov, Karen L. Laurie, et al. · Infection Genetics and Evolution · 13
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity
2025 · Tirta M. Djajawi, Anne Huber, et al. · Cell Reports · 4
A TAK1Cytokine Toxicity Checkpoint Controls Anti-Cancer Immunity
2025 · Tirta M Djajawi, Anne Huber, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
319 Elucidation of tumor cell killing and immune escape pathways in the context of human γδ T cell immune responses
2026 · Kok Fei Chan, Tianming Li, et al. · Journal for ImmunoTherapy of Cancer
PDF
Characterisation of tumor‐infiltrating gamma‐delta T cells in human colorectal cancer with MHC‐I loss
2026 · Tianming A Li, Luke T Quigley, et al. · Clinical & Translational Immunology
360 Understanding the mechanisms of tumor immune evasion from Vδ1+ γδ T cell-mediated killing using genome-wide CRISPR-Cas9 loss-of-function screens
2025 · Kok Fei Chan, Tianming Li, et al. · Journal for ImmunoTherapy of Cancer
PDF
A Tak1 Cytokine Toxicity Checkpoint Controls Anti-Cancer Immunity
2025 · Tirta M. Djajawi, Anne Huber, et al. · SSRN Electronic Journal
431 Tumor immune evasion under Vδ2+ γδ T cell immune pressure
2024 · Kok Fei Chan, Tianming Li, et al. · Journal for ImmunoTherapy of Cancer
442-P Characterizing human Vδ1+ and Vδ2+ γδ T cells for tumor immunotherapy development
2023 · Kok Fei Chan, Tianming Li, et al. · Journal for ImmunoTherapy of Cancer
192 Characterization of antibodies against BTN2A1 for Vδ2+γδ T cell-based tumor immunotherapy
2022 · Kok Fei Chan, Simone Ostrouska, et al. · Journal for ImmunoTherapy of Cancer
PDF
Structural basis for polyclonal T-cell receptor recognition of a 13 mer peptide from tumour antigen NY-ESO-1 presented by HLA-B*0702
2014 · Kok Fei Chan · Minerva Access (University of Melbourne)
Works count: 17
Citation count: 414
H-index: 7
I10-index: 7
Year
Topic
Type